Sex hormones fail to influence all-cause, CVD mortality in middle-aged men

HORMONE THERAPY Mortality and cardiovascular disease outcomes are not influenced by testosterone, dihydrotestosterone or estradiol in predominantly middle-aged men, study data show. Bu B. Yeap, PhD, MBBS, FRACP, professor in the school of medicine and pharmacology at the University of Western Austra...

Full description

Saved in:
Bibliographic Details
Published inEndocrine Today Vol. 14; no. 11; p. 50
Main Authors Cox, Amber, Douglass, Paul L
Format Trade Publication Article
LanguageEnglish
Published Thorofare SLACK INCORPORATED 01.11.2016
Subjects
Disclosure
Hormone replacement therapy
Middle age
Mortality
Researchers
Testosterone
Atlanta Georgia
Online AccessGet full text

Cover

More Information
Summary:HORMONE THERAPY Mortality and cardiovascular disease outcomes are not influenced by testosterone, dihydrotestosterone or estradiol in predominantly middle-aged men, study data show. Bu B. Yeap, PhD, MBBS, FRACP, professor in the school of medicine and pharmacology at the University of Western Australia in Perth, and colleagues evaluated data from the 19941995 Busselton Health Survey on 1,804 men (mean age, 50.3 years) to determine the relationships between endogenous sex hormones and mortality and CVD events. [...]this was a homogenous population that probably cannot be extrapolated to countries with more diverse populations. [...]this observational study with a large population adds to the debate, but does not answer the cause-and-effect question.
ISSN:1540-0735